Skip to Main Content

+1 (508) 881-6771

Human Tissue Models

Mattek’s lab-grown human epithelial tissues are living, metabolically active 3D tissue models that provide greater insight into clinical outcomes.

EpiAlveolar™

Product Overview

Primary Cells Media

Mattek’s decades-long expertise in cell isolation and expansion has created a large and diverse inventory of primary cells from native donor tissue. 3D-certified cells for elevated biological research.

Cultureware

Mattek Dishes have set the benchmark for cell culture and imaging excellence for nearly 40 years. Experience the optical clarity and precision of glass in a Petri dish.

Visikol Products

We offer several reagents and supporting materials that provide researchers with an unprecedented view of tissues for enhanced characterization.

News & Resources

December 11, 2015

RETROSPECTIVE ANALYSIS OF THE EPIDERM 3-MINUTE PREDICTION MODEL FOR ASSESSMENT OF GHS SKIN CORROSION PACKING GROUP SUB-CATEGORY 1A.

OECD has adopted several ECVAM-validated reconstructed human skin models (EpiDerm and EPISKIN/SkinEthic) for testing skin corrosion as...

December 11, 2015

COMPARISON OF CORROSITEX AND EPIDERM IN VITRO SKIN CORROSION SCREENING ASSAYS TO IN VIVO CORROSIVITY RESULTS.

This study by researchers at Dow Chemical Co. demonstrated that Mattek’s EpiDerm human skin tissue equivalent gave...

December 11, 2015

A TRIPLE CELL CO-CULTURE MODEL OF THE AIR-BLOOD BARRIER RECONSTRUCTED FROM PRIMARY HUMAN CELLS.

Reliable in vitro human models for investigating airway toxicity are needed to advance Tox21 efforts to replace...

December 11, 2015

SURFACTANT-LIKE PROPERTIES OF ALKALINE EXTRACTS FROM WASTEWATER BIOSOLIDS.

In order to assess the potential for utilizing wastewater biosolids as a source of useful substances, the...

December 11, 2015

THE SKIN CANCER CHEMOTHERAPEUTIC AGENT INGENOL-3-ANGELATE (PEP005) IS A SUBSTRATE FOR THE EPIDERMAL MULTIDRUG TRANSPORTER (ABCB1) AND TARGETS TUMOR VASCULATURE.

Ingenol-3-angelate (Ing3A), extracted from Euphorbia peplus, is currently in clinical trials for eradicating basal cell carcinoma, actinic...